Precision medicine

Closer pathology-oncology care team coordination is key to leverage the value of precision therapies and improve outcomes

Could a new multi omics microsampling platform “Amazonize” healthcare?

How does progress in sequencing technology impact studies in cancer genomics?

Lung cancer patients can’t always wait for treatment – so rapid in-house NGS can facilitate precision therapy fast

Rapid, reliable, widespread whole genome sequencing could shorten the rare disease diagnostic odyssey and improve patients’ lives

Overcoming lung cancer treatment resistance requires predictive biomarkers that take into account patient variability

In an aging world with cancer cases increasing, it’s time for technology

Size isn’t everything when it comes to next-generation sequencing. For one NHS consortium, using multiple panels is changing the game

Not all patients respond to cancer immunotherapy – so how can we identify those who won’t and seek out better treatment options for them?

Do you know how to choose the right panel size when providing NGS testing for cancer patients?